4.5 Review

Resveratrol as sensitizer in colorectal cancer plasticity

Related references

Note: Only part of the references are listed.
Review Food Science & Technology

A comprehensive overview of the complex relationship between epigenetics, bioactive components, cancer, and aging

Sule Kocabas et al.

Summary: The incidence of cancer increases with aging due to shared molecular pathways. While genetics only accounts for about 20-25% of human lifespan, epigenetic changes play a significant role in individual health and aging. Both genetic and environmental factors, including diet, can modify aging and age-related diseases. Epigenetics shows promise in preventing and managing certain cancers and diseases, with specific nutritional components having a significant impact on gene regulatory processes.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2023)

Review Oncology

Novel strategies to reverse chemoresistance in colorectal cancer

Shu-Chang Ma et al.

Summary: Colorectal cancer is a common gastrointestinal malignancy with high morbidity and fatality. Chemotherapy is effective in treating CRC, but chemoresistance limits its efficacy. Strategies such as drug repurposing, gene therapy, protein inhibitors, natural herbal compounds, new drug delivery systems, and combination therapy are being investigated to overcome chemoresistance.

CANCER MEDICINE (2023)

Article Medicine, Research & Experimental

Resveratrol improves hepatic ischemia-reperfusion injury by inhibiting neutrophils via the ERK signaling pathway

Yaning Wang et al.

Summary: This study found that preintervention with resveratrol ameliorated hepatic injury and neutrophil inflammatory responses in hepatic ischemia-reperfusion injury (HIRI). Resveratrol inhibited neutrophil functions such as survival, cell cycle, migration, and chemotaxis, as well as oxidative stress and secretion of proinflammatory cytokines. The mechanism of action involved the inhibition of endothelin 1 autocrine signaling through the suppression of the ERK pathway.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Biochemistry & Molecular Biology

Resveratrol Modulates Chemosensitisation to 5-FU via beta 1-Integrin/HIF-1 alpha Axis in CRC Tumor Microenvironment

Aranka Brockmueller et al.

Summary: Resveratrol can enhance the sensitivity of colorectal cancer cells to 5-FU by regulating the beta 1-integrin/HIF-1α signaling axis, leading to suppression of cancer cell growth and invasion, inhibition of inflammation and cancer stem cell production. These findings highlight the potential application of resveratrol in the treatment of colorectal cancer by overcoming chemoresistance to 5-FU.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies

Zhen-Duo Shi et al.

Summary: Despite the success of targeted therapies in cancer treatment, therapy-induced resistance remains a major obstacle. Tumor cells utilize phenotypic switching driven by cell plasticity to evade treatments and relapse. Various reversible mechanisms, including epigenetic modifications and signaling pathway regulation, have been proposed to overcome tumor cell plasticity. In this review, we discuss the formation of tumor cell plasticity, its impact on targeted therapy evasion, and the development of new therapeutic strategies and combination therapies that target tumor cell plasticity.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Cell Biology

Modulation of lncRNA H19 enhances resveratrol-inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress

Tianye Li et al.

Summary: Resveratrol inhibits the survival of gastric tumor cells by promoting apoptosis, autophagy, and endoplasmic reticulum stress. It also alters the expression of several long non-coding RNAs, and knockdown of H19 enhances the therapeutic effect of resveratrol.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)

Review Biochemistry & Molecular Biology

Anti-Osteoporotic Mechanisms of Polyphenols Elucidated Based on In Vivo Studies Using Ovariectomized Animals

Yoshimi Niwano et al.

Summary: Polyphenols, including resveratrol, have antioxidant and anti-inflammatory properties that can regulate the balance between bone formation and resorption, making them a potentially safe and effective treatment for postmenopausal osteoporosis.

ANTIOXIDANTS (2022)

Article Oncology

Suppressive effect of α-mangostin for cancer stem cells in colorectal cancer via the Notch pathway

Min Kyoung Jo et al.

Summary: This study demonstrates that low-dose alpha M selectively inhibits CRC CSCs and suppresses the 5-FU-induced augmentation of CSCs through the Notch signaling pathway.

BMC CANCER (2022)

Review Oncology

A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities

Hossein Moutabian et al.

Summary: This study aimed to review the potential therapeutic effects of resveratrol in combination with 5-fluorouracil (5-FU) against colorectal cancer. The results demonstrated that co-administration of resveratrol could sensitize the colorectal cancer cells to 5-FU treatment via various mechanisms.

CANCER CELL INTERNATIONAL (2022)

Article Pharmacology & Pharmacy

Resveratrol ameliorates high-phosphate-induced VSMCs to osteoblast-like cells transdifferentiation and arterial medial calcification in CKD through regulating Wnt/?-catenin signaling

Xiaowen Huang et al.

Summary: Resveratrol possesses a vascular protective effect by targeting Wnt/β-catenin signaling to retard the development of arterial medial calcification in patients with chronic kidney disease.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Cell Biology

Resveratrol Ameliorates Deep Vein Thrombosis-Induced Inflammatory Response Through Inhibiting HIF-1α/NLRP3 Pathway

Jianwen Fei et al.

Summary: This study aimed to investigate the effect of resveratrol (Res) on deep vein thrombosis (DVT) and explore its mechanism. The results showed that Res effectively ameliorated DVT in rats by inhibiting the HIF-1 alpha/NLRP3 pathway. This provides a novel therapeutic strategy for DVT treatment.

INFLAMMATION (2022)

Article Biochemistry & Molecular Biology

Calebin A, a Compound of Turmeric, Down-Regulates Inflammation in Tenocytes by NF-κB/Scleraxis Signaling

Anna-Lena Mueller et al.

Summary: The study revealed that Calebin A can alleviate tendonitis inflammation by inhibiting the adhesion between T-lymphocytes and tenocytes and modulating NF-kappa B/Scleraxis signaling, indicating its potential as a preventive and therapeutic agent for tendonitis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

PRP4 Induces Epithelial-Mesenchymal Transition and Drug Resistance in Colon Cancer Cells via Activation of p53

Salman Ul Islam et al.

Summary: PRP4 promotes pre-mRNA splicing and signal transduction. It induces drug resistance and EMT by binding to p53 and activating miR-210 and HIF-1α. Inhibition of PRP4 could benefit patients with colon cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model

Camille Jacques et al.

Summary: This study evaluated the immunomodulatory effects of MIM-seq on human macrophages and its potential anti-tumor properties against colorectal cancer (CRC). The results showed that MIM-seq inhibited pro-inflammatory cytokine secretion and displayed anti-proliferative effects on tumor cells. When combined with other anti-cancer agents, MIM-seq further reduced tumor growth, suggesting its potential as an adjuvant therapy for CRC patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Resveratrol Inhibition of the WNT/β-Catenin Pathway following Discogenic Low Back Pain

Tiziana Genovese et al.

Summary: Resveratrol administration can alleviate behavioral changes, inflammation, and oxidative stress induced by low back pain (LBP). It regulates the WNT/beta-catenin pathway and related gene expressions, which reduces LBP symptoms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Evidence That beta 1-Integrin Is Required for the Anti-Viability and Anti-Proliferative Effect of Resveratrol in CRC Cells

Aranka Brockmueller et al.

Summary: This study found that resveratrol can exert its suppressive actions on tumor microenvironment (TME)-induced tumorigenesis in colorectal cancer (CRC) cells through the beta 1-integrin receptor. Resveratrol altered the distribution pattern and expression of beta 1-integrin on the surface of CRC cells in TME, leading to decreased cell proliferation and viability, and increased apoptosis. Inhibition of beta 1-integrin or interruption of downstream signaling pathway attenuated the anti-tumor effects of resveratrol. The results highlight the important role of beta 1-integrins as signal carriers for resveratrol in CRC cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

Resveratrol Attenuates High-Fat Diet-Induced Hepatic Lipotoxicity by Upregulating Bmi-1 Expression

Weigang Yuan et al.

Summary: Resveratrol has been shown to alleviate hepatic lipotoxicity by reducing apoptosis, mitochondrial dysfunction, and oxidative stress. The protective effects are associated with increased expression of Bmi-1 and antioxidative superoxide dismutase.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)

Review Oncology

Natural Lignans Honokiol and Magnolol as Potential Anticarcinogenic and Anticancer Agents. A Comprehensive Mechanistic Review

Sayeh Mottaghi et al.

Summary: Plant lignans are important polyphenols that have been shown to induce cancer cell death and suppress proliferation with minimal toxicity to normal cells. Epidemiological studies suggest that lignans intake is associated with lower cancer risk. Honokiol and magnolol, two natural lignans, exhibit potent anticancer activities against various human cancers.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2022)

Article Biochemistry & Molecular Biology

Resveratrol Decreases the Invasion Potential of Gastric Cancer Cells

Daniel Rojo et al.

Summary: Resveratrol inhibits the invasion potential of gastric cancer cells by increasing SOD activity and decreasing NF-kappa B transcriptional activity and heparanase enzymatic activity.

MOLECULES (2022)

Article Pharmacology & Pharmacy

Resveratrol improves diabetic cardiomyopathy by preventing asymmetric dimethylarginine-caused peroxisome proliferator-activated receptor-? coactivator-1? acetylation

Wei-Jin Fang et al.

Summary: The study found that resveratrol improves mitochondrial function and protects the heart by activating SIRT1 and deacetylating PGC-1 alpha. Additionally, resveratrol can reverse the pathogenic role of ADMA in diabetic cardiomyopathy and restore altered PGC-1 alpha expression and acetylation. Exogenous ADMA reproduces cardiac and mitochondrial dysfunction, which can be prevented by resveratrol pretreatment.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Oncology

Second Cancer After Additive Chemotherapy in Patients With Colon Cancer

Andreas Teufel et al.

Summary: The study investigated the risk of second cancer development in patients with colon cancer after adjuvant chemotherapy. The results showed that there was no significantly increased risk of subsequent second cancer after chemotherapy. Interestingly, patients treated with FOLFOX had a decreased rate of second cancer compared to those treated with FUFOL. These findings have implications for the surveillance and long-term follow-up of cancer patients.

CLINICAL COLORECTAL CANCER (2022)

Review Pharmacology & Pharmacy

Role of Drug Delivery System in Improving the Bioavailability of Resveratrol

Zonish Saleem et al.

Summary: This article investigates methods to improve the bioavailability and pharmacokinetic properties of Resveratrol (RSV) and highlights the challenges in its delivery processes. The study summarizes different drug delivery strategies such as the micro-particulate system, microencapsulation, cyclodextrin system, and nanosponge formulations.

CURRENT PHARMACEUTICAL DESIGN (2022)

Article Gastroenterology & Hepatology

Dietary and lifestyle associations with microbiome diversity

Katherine M. M. Watson et al.

Summary: This study demonstrates the association between dietary habits, adenoma formation, and the mucosal microbiome, suggesting that modifying diet may help reduce adenoma formation and subsequently prevent colorectal cancer.

GUT PATHOGENS (2022)

Article Nutrition & Dietetics

Suffruticosol C-Mediated Autophagy and Cell Cycle Arrest via Inhibition of mTORC1 Signaling

Senlin Qin et al.

Summary: Suffruticosol C from peony seeds induces autophagy and cell cycle arrest, possibly regulating cancer cell viability by inhibiting mTORC1 signaling.

NUTRIENTS (2022)

Article Pharmacology & Pharmacy

Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury

Hasnaa A. Ebrahim et al.

Summary: This study investigated the link between liver fibrosis and hypertension induced by thioacetamide, as well as the role of inflammation, nuclear factor-kappa B, nitrosative stress, and hypoxia-inducible factor-1 alpha. The findings suggest that the anti-inflammatory and antioxidant resveratrol can ameliorate the fibrosis and hypertension caused by thioacetamide.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)

Review Oncology

Drug Resistance in Colorectal Cancer: From Mechanism to Clinic

Qianyu Wang et al.

Summary: Chemotherapy, radiotherapy and molecularly targeted therapy have shown promising results in improving prognosis of colorectal cancer patients. Immunotherapy, especially immune checkpoint inhibitors, has also significantly enhanced patient outcomes. However, drug resistance remains a major challenge, with mechanisms including aberrant anti-tumor drug metabolism, transportation, target, cell death pathways, carcinogenic signals, compensation feedback loop signal pathways, and tumor immune microenvironment playing crucial roles. Further research into these mechanisms may lead to potential therapeutic interventions.

CANCERS (2022)

Review Chemistry, Medicinal

Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks

Vincenzo Sorrenti et al.

Summary: Aging is a result of the dysregulation of multiple molecular pathways, with mTOR and AMPK signaling playing a role in cellular senescence. Poor nutritional balance is a driving factor in immunosenescence progression, and nutraceutical and pharmacological interventions can help maintain optimal biological response. Compounds like resveratrol, rapamycin, and metformin have shown positive effects in healthy aging.

PHARMACEUTICALS (2022)

Article Oncology

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer

Chi-Che Hsieh et al.

Summary: This study reveals that CHK2 activity is critical for modulating the response to oxaliplatin in CRC cells. We demonstrate that CHK2 plays a key role in oxaliplatin-induced DNA repair and suggest that targeting CHK2 may be a potential therapeutic strategy for oxaliplatin-resistant CRC.

BRITISH JOURNAL OF CANCER (2022)

Article Pharmacology & Pharmacy

Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells

Annie Cristhine Moraes Sousa-Squiavinato et al.

Summary: A long-term drug-resistant colorectal cancer model was established to explore the cellular events underlying 5-fluorouracil (5FU) resistance. The study identified various cellular events and molecular changes associated with 5FU resistance, as well as specific genes that could predict poor outcomes in colorectal cancer patients. The findings highlight the importance of identifying promising targets involved in multiple cellular events to overcome drug resistance.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Resveratrol Ameliorates High Altitude Hypoxia-Induced Osteoporosis by Suppressing the ROS/HIF Signaling Pathway

Changqing Yan et al.

Summary: The study found that resveratrol can alleviate high-altitude hypoxia-induced osteoporosis by promoting osteoblastogenesis and inhibiting osteoclastogenesis.

MOLECULES (2022)

Article Orthopedics

Resveratrol protection against IL-1β-induced chondrocyte damage via the SIRT1/FOXO1 signaling pathway

ChuanCai Liang et al.

Summary: This study shows that resveratrol regulates the pathogenesis of osteoarthritis through the SIRT1/FOXO1 pathway, promoting chondrocyte autophagy, inhibiting apoptosis and matrix breakdown, and protecting chondrocytes from damage.

JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2022)

Article Food Science & Technology

Role of PI3K/Akt-Mediated Nrf2/HO-1 Signaling Pathway in Resveratrol Alleviation of Zearalenone-Induced Oxidative Stress and Apoptosis in TM4 Cells

Wenlin Xu et al.

Summary: This study demonstrates that resveratrol (RSV) can protect cells and alleviate oxidative stress and apoptosis induced by zearalenone (ZEA) through the PI3K/Akt signaling pathway.

TOXINS (2022)

Review Oncology

Advances in Dietary Phenolic Compounds to Improve Chemosensitivity of Anticancer Drugs

Abdelhakim Bouyahya et al.

Summary: Several dietary phenolic compounds isolated from medicinal plants have significant anticancer effects. They induce apoptosis, autophagy, telomerase inhibition, and angiogenesis. These compounds increase the effectiveness of conventional chemotherapy drugs and have shown remarkable therapeutic results in treating certain cancers. However, chemoresistance is still a challenge in cancer treatment, and combining multiple anticancer agents can help overcome resistance and improve therapeutic efficacy.

CANCERS (2022)

Review Oncology

Multifunctionality of Calebin A in inflammation, chronic diseases and cancer

Aranka Brockmueller et al.

Summary: Chronic diseases, including cancer, have high case numbers and mortality rates. The complexity and involvement of various inflammatory pathways in their pathogenesis make the efficient treatment of chronic diseases a global medical challenge. Current research focuses on exploring the anti-inflammatory and anti-cancer properties of polyphenols, such as Calebin A from turmeric, to complement and enhance the effects of conventional anti-inflammatory drugs and chemotherapeutic agents.

FRONTIERS IN ONCOLOGY (2022)

Review Medicine, General & Internal

Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: A mini-review

Lei Chen et al.

Summary: This study reviews the mechanisms of chemotherapy resistance in colorectal cancer (CRC), primarily focusing on cancer stem cells (CSCs). The research also discusses potential strategies to overcome chemotherapy resistance and eliminate CSCs, providing promising insights for CRC treatment.

FRONTIERS IN MEDICINE (2022)

Article Biochemistry & Molecular Biology

Computational analysis of nuclear factor-κB and resveratrol in colorectal cancer

Begum Dariya et al.

Summary: NF-kappa B is a major regulator of the biological characteristics of tumor cells, and antioxidants or protease inhibitors may suppress colorectal cancer. Computational studies suggest NF-kappa B could be a potential target for anti-cancer drugs.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Endocrinology & Metabolism

Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model

Ning Zhang et al.

Summary: The study demonstrated that resveratrol treatment may increase plasma adiponectin and estradiol levels in PCOS model animals and restore normal ovarian morphology. Additionally, the treatment was associated with increased ovarian expression of nesfatin-1 and aromatase.

GYNECOLOGICAL ENDOCRINOLOGY (2021)

Review Chemistry, Medicinal

Phytoestrogens for the Management of Endometriosis: Findings and Issues

Xia Cai et al.

Summary: This article reviews the relationship between phytoestrogen intake and the risk of endometriosis, analyzing findings from in vitro experiments, rodent endometriotic models, and human intervention trials. While resveratrol, isoflavones, and puerarin showed favorable results in endometrial primary cultures and animal models, only resveratrol exhibited promising results in human intervention trials.

PHARMACEUTICALS (2021)

Article Cell & Tissue Engineering

Resveratrol benefits the lineage commitment of bone marrow mesenchymal stem cells into osteoblasts via miR-320c by targeting Runx2

Jilong Zou et al.

Summary: Bone marrow mesenchymal stem cells (BMSCs) can be induced to differentiate into osteoblasts and inhibit adipogenesis by resveratrol (RSVL), with miR-320c playing a crucial regulatory role in this process.

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2021)

Article Oncology

Catechol enhances chemo- and radio-sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells

Jeong Yong Moon et al.

Summary: Research indicates that catechol can inhibit proliferation, promote apoptosis, reduce cell migration, invasion, and EMT, and enhance the chemo- and radio-sensitivity of Panc-1 cells by targeting the AMPK/Hippo signaling pathway.

ONCOLOGY REPORTS (2021)

Review Biochemistry & Molecular Biology

Phytoestrogens (Resveratrol and Equol) for Estrogen-Deficient Skin-Controversies/Misinformation versus Anti-Aging In Vitro and Clinical Evidence via Nutraceutical-Cosmetics

Edwin D. Lephart

Summary: This review explores the relationship between superfoods, phytoestrogens, and endocrine-disruptors, emphasizing the importance of perspective in understanding these controversial issues.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Resveratrol promotes the survival and neuronal differentiation of hypoxia-conditioned neuronal progenitor cells in rats with cerebral ischemia

Yao Yao et al.

Summary: This study demonstrated that resveratrol, an herbal compound, can enhance mitochondrial metabolism of hypoxia-conditioned neuronal progenitor cells (hcNPCs), promoting neuronal differentiation and improving neurological and metabolic recovery in stroke rats.

FRONTIERS OF MEDICINE (2021)

Review Oncology

Resveratrol's Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism

Aranka Brockmueller et al.

Summary: Resveratrol, a well-studied polyphenol, has the potential to complement traditional tumor therapy by targeting multiple signal transduction pathways involved in cancer processes like inflammation, angiogenesis, proliferation, metastasis, glucose metabolism, and apoptosis. Tumor cells display the Warburg effect, where they reprogram their metabolism to favor aerobic glycolysis, creating a low pH environment that promotes their survival and resistance to apoptosis. Resveratrol's ability to modulate tumor glucose metabolism and target multiple components in signaling pathways makes it a promising therapeutic agent in cancer treatment.

CANCERS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis-An In Vitro Study

Eszter Fidrus et al.

Summary: The high incidence of skin cancers in the Caucasian population is primarily due to DNA damage induced by chronic UVB exposure. This study investigated the effects of NER-inhibitor molecules on UVB-induced DNA damage and mutagenesis in vitro, finding that while these molecules increased CPD levels, they did not enhance mutagenic effects. These findings suggest the importance of considering metabolic cellular response pathways in evaluating the skin cancer risk-modifying effects of pharmacological compounds.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives

Veronica Cocetta et al.

Summary: Resistance to chemotherapy remains a challenge in cancer treatment, but resveratrol has shown promise as a chemosensitizer by modulating cancer-related molecular mechanisms. Despite its low bioavailability, efforts are being made to improve drug delivery strategies for more effective use in therapy-refractory cancer patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Medicinal

Peonidin-3-O-glucoside and cyanidin increase osteoblast differentiation and reduce RANKL-induced bone resorption in transgenic medaka

Zhitao Ren et al.

Summary: Anthocyanins and resveratrol have been shown to promote proliferation and differentiation of human osteoblasts, reduce apoptosis, and regulate mitochondrial and epigenetic pathways, suggesting potential benefits for bone health.

PHYTOTHERAPY RESEARCH (2021)

Review Biochemistry & Molecular Biology

Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment

Gagan Chhabra et al.

Summary: Resveratrol, a natural stilbenoid found in red grapes, has been extensively studied for its immunomodulatory effects on various human diseases, including cancer. Recent research has shown that resveratrol can regulate signaling pathways and cellular events, indicating its potential use in cancer management, especially in combination with other therapies such as immunotherapy.

MOLECULES (2021)

Article Oncology

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines

Tomonari Suetsugu et al.

Summary: Fluorouracil (5FU) is converted to its active metabolite fluoro-deoxyuridine monophosphate (FdUMP) through different pathways in different cells, contributing to varying mechanisms of resistance. When overcoming 5FU resistance, both the synthesized amount of FdUMP and sensitivity to FdUMP should be taken into consideration.

ONCOLOGY REPORTS (2021)

Review Cell Biology

Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer

Sabesan Yoganathan et al.

Summary: Multidrug resistance, primarily mediated by P-glycoprotein (P-gp), poses a major challenge in cancer treatment. Developing small molecules to modulate P-gp activity can enhance cancer cell sensitivity to anticancer drugs. Natural polyphenols, including ellagic acid and derivatives, have emerged as promising compounds to overcome this mode of drug resistance.

CELLS (2021)

Article Oncology

Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line

Zhuo-Xun Wu et al.

Summary: Colorectal cancer is a leading cause of cancer-related deaths globally, with irinotecan commonly used as a chemotherapeutic drug. A new irinotecan-resistant colon cell line was established in this study, showing overexpression of ABC transporters as a potential mechanism of resistance. This research provides a novel in vitro model for studying irinotecan resistance and suggests targeting ABCG2 may help overcome drug resistance in colorectal cancer treatment.

FRONTIERS IN ONCOLOGY (2021)

Article Pharmacology & Pharmacy

In vitro and in vivo combinatorial anticancer effects of oxaliplatin- and resveratrol-loaded N,O-carboxymethyl chitosan nanoparticles against colorectal cancer

Yaowen Wang et al.

Summary: The combination of oxaliplatin and resveratrol into nanoparticles using NDDSs shows promising potential for colorectal cancer therapy, with higher encapsulation efficiency and anti-cancer activity compared to free drugs or standalone nanoparticles usage. The combined application of these nanoparticles demonstrates stronger inhibitory effects against colon cancer in in vivo experiments.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Article Biochemistry & Molecular Biology

Resveratrol ameliorates sevoflurane-induced cognitive impairment by activating the SIRT1/NF-κB pathway in neonatal mice

Xiao Le Tang et al.

Summary: Sevoflurane exposure leads to cognitive impairment in developing mice, which is ameliorated by resveratrol treatment through modulating the balance of microglia functions in the SIRT1 and NF-kappa B pathways.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis

Yupeng Liu et al.

Summary: Resveratrol acts against cisplatin-induced ototoxicity by regulating miR-455-5p expression and activating the PI3K-Akt signaling pathway. It promotes cell survival and reduces apoptosis through these mechanisms. In addition, resveratrol protects hearing and mitigates cisplatin-induced damage to hair cells.

BIOCHEMISTRY AND CELL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Resveratrol Attenuates the Proliferation of Prostatic Stromal Cells in Benign Prostatic Hyperplasia by Regulating Cell Cycle Progression, Apoptosis, Signaling Pathways, BPH Markers, and NF-κB Activity

Jowon Jang et al.

Summary: Resveratrol inhibits abnormal proliferation of prostate stromal cells by inducing cell cycle arrest, suppressing multiple signaling pathways, reducing molecular markers affecting prostate development, and promoting apoptosis. These findings suggest that resveratrol may be beneficial for the prevention or treatment of prostatic hyperplasia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Resveratrol ameliorated endothelial injury of thoracic aorta in diabetic mice and Gly-LDL-induced HUVECs through inhibiting TLR4/HIF-1α

Wenjun Sha et al.

Summary: The study showed that resveratrol alleviates endothelial injury in diabetic mice and HUVECs by inhibiting the TLR4/HIF-1 alpha signaling pathway, reducing inflammatory cytokine levels, which may have potential therapeutic benefits for diabetes.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

A Brief Updated Review of Advances to Enhance Resveratrol's Bioavailability

Konrad de Vries et al.

Summary: Studies have shown that RES analogues exhibit heightened activity compared to their parent compound, but clinical trials are still lacking to confirm this increased activity.

MOLECULES (2021)

Article Neurosciences

Resveratrol inhibits inflammation after spinal cord injury via SIRT-1/NF-κB signaling pathway

Haosen Zhao et al.

Summary: The study found that resveratrol treatment promoted motor function recovery in rats after SCI, increased the expression of brain-derived neurotrophic factor, and reduced loss of motor neurons and lesion size. Additionally, inflammatory response was inhibited by modulating the SIRT-1/NF-kappa B signaling pathway.

NEUROSCIENCE LETTERS (2021)

Review Chemistry, Medicinal

Boosting immune system against cancer by resveratrol

Libo Chen et al.

Summary: Immune system modulation is crucial in cancer therapy, aiming to boost immune system cells and suppress immunosuppressive responses. Agents like resveratrol have shown the ability to enhance antitumor immunity by inducing the release of anticancer cytokines and sensitizing cancer cells to immune signals.

PHYTOTHERAPY RESEARCH (2021)

Article Medicine, Research & Experimental

Resveratrol reduces the progression of titanium particle-induced osteolysis via the Wnt/β-catenin signaling pathway in vivo and in vitro

Xi Chen et al.

Summary: Resveratrol, an activator of sirtuin 1, has been extensively studied as an anti-inflammatory and anti-aging drug. The study showed that resveratrol can inhibit titanium particle-induced osteolysis by activating the Wnt/beta-catenin signaling pathway in both in vitro and in vivo models, promoting bone cell viability and osteogenesis.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Biology

Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization

Joshua D. Greenlee et al.

Summary: This study demonstrates that oxaliplatin-resistant CRC cells become more sensitive to TRAIL-mediated apoptosis due to increased DR4 expression, palmitoylation, and translocation. The alteration of DR4/raft colocalization and TRAIL sensitivity by raft perturbation via nystatin and resveratrol is significant. Additionally, treatment with TRAIL liposomes in blood samples from metastatic CRC patients results in a reduction of viable CTCs, with increased DR4/lipid raft colocalization corresponding to increased oxaliplatin resistance and efficacy of TRAIL liposomes.

ELIFE (2021)

Article Medicine, Research & Experimental

Exploring the Inflammatory Pathogenesis of Colorectal Cancer

Ahamed A. Khalyfa et al.

Summary: Inflammation plays a crucial role in the formation of colorectal cancer, impacting disease progression, metastasis, and traditional risk factors such as obesity, smoking, and diabetes. By studying colon cancer from an inflammatory perspective, a comprehensive understanding of the disease is achieved, providing unique opportunities for prevention, early diagnosis, and therapy.

DISEASES (2021)

Article Biochemistry & Molecular Biology

LncRNA-cCSC1 modulates cancer stem cell properties in colorectal cancer via activation of the Hedgehog signaling pathway

He Zhou et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Article Cell Biology

Chondroprotective and anti-inflammatory effects of amurensin H by regulating TLR4/Syk/NF-κB signals

Pei Ma et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Review Cell Biology

Immune checkpoint signaling and cancer immunotherapy

Xing He et al.

CELL RESEARCH (2020)

Article Cell & Tissue Engineering

Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer

Arianna Fumagalli et al.

CELL STEM CELL (2020)

Article Oncology

Resveratrol binds and inhibits transcription factor HIF-1 alpha in pancreatic cancer

Gowru Srivani et al.

EXPERIMENTAL CELL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Calebin A Potentiates the Effect of 5-FU and TNF-β (Lymphotoxin α) against Human Colorectal Cancer Cells: Potential Role of NF-κB

Constanze Buhrmann et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Immunological Mechanisms in Inflammation-Associated Colon Carcinogenesis

Takehiro Hirano et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, Research & Experimental

Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice

Yixuan Jiang et al.

LIFE SCIENCES (2020)

Article Immunology

The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives

Milad Ashrafizadeh et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Article Multidisciplinary Sciences

5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation

Yong-Hee Cho et al.

NATURE COMMUNICATIONS (2020)

Article Orthopedics

Resveratrol alleviates the interleukin-1β-induced chondrocytes injury through the NF-κB signaling pathway

Hong Yi et al.

JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2020)

Review Biochemistry & Molecular Biology

Emerging role of tumor cell plasticity in modifying therapeutic response

Siyuan Qin et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Medicine, General & Internal

The Role of Cyclooxygenase-2 in Colorectal Cancer

Juan Sheng et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)

Article Food Science & Technology

Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin

Desiree Martinez-Martinez et al.

FOOD AND CHEMICAL TOXICOLOGY (2019)

Article Oncology

Resveratrol induces p53 in colorectal cancer through SET7/9

Zhonglun Liu et al.

ONCOLOGY LETTERS (2019)

Article Biochemistry & Molecular Biology

Resveratrol attenuates inflammation environment-induced nucleus pulposus cell senescence in vitro

Xiaoming Li et al.

BIOSCIENCE REPORTS (2019)

Article Biochemistry & Molecular Biology

Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure

Maria Giovanna Francipane et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Geriatrics & Gerontology

Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway

Nanqu Huang et al.

EXPERIMENTAL GERONTOLOGY (2019)

Article Biochemistry & Molecular Biology

Resveratrol up-regulates ATP2A3 gene expression in breast cancer cell lines through epigenetic mechanisms

Eduardo Izquierdo-Torres et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway

Yin-Gi Jang et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)

Article Pharmacology & Pharmacy

Are the cardioprotective effects of the phytoestrogen resveratrol sex-dependent?

Xavier Lieben Louis et al.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2019)

Article Medicine, Research & Experimental

Evidence that TNF-β induces proliferation in colorectal cancer cells and resveratrol can down-modulate it

Constanze Buhrmann et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2019)

Article Medicine, Research & Experimental

Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway

Dan Li et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Ferulic acid reverses P-glycoprotein-mediated multidrug resistance via inhibition of PI3K/Akt/NF-kappa B signaling pathway

Ganesan Muthusamy et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Evodiamine Eliminates Colon Cancer Stem Cells via Suppressing Notch and Wnt Signaling

Hyejin Kim et al.

MOLECULES (2019)

Article Medicine, Research & Experimental

Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways

Jing Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Oncology

Resveratrol induces autophagy-dependent apoptosis in HL-60 cells

Yingying Fan et al.

BMC CANCER (2018)

Article Oncology

Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells

Min Zhou et al.

INTERNATIONAL JOURNAL OF CANCER (2018)

Article Immunology

Targeting tumor cell plasticity by combined inhibition of NOT CH and MAPK signaling in colon cancer

Eva Marina Schmidt et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Review Food Science & Technology

Cruciferous Vegetables and Risk of Cancers of the Gastrointestinal Tract

Ian T. Johnson

MOLECULAR NUTRITION & FOOD RESEARCH (2018)

Article Nutrition & Dietetics

Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells

Constanze Buhrmann et al.

NUTRIENTS (2018)

Article Biochemistry & Molecular Biology

Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles

Rebeca Penalva et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Multidisciplinary Sciences

Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition

Lihua Peng et al.

PLOS ONE (2018)

Review Gastroenterology & Hepatology

Drug resistance and new therapies in colorectal cancer

Kevin Van der Jeught et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Review Oncology

Differentiation therapy revisited

Hugues de The

NATURE REVIEWS CANCER (2018)

Article Cell Biology

Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer

Anya Alayev et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2017)

Article Biochemistry & Molecular Biology

Resveratrol stimulates the metabolic reprogramming of human CD4+ T cells to enhance effector function

Marco Craveiro et al.

SCIENCE SIGNALING (2017)

Article Biochemistry & Molecular Biology

The role of GLI1 for 5-Fu resistance in colorectal cancer

Lining Zhang et al.

CELL AND BIOSCIENCE (2017)

Article Biochemistry & Molecular Biology

Resveratrol stimulates the metabolic reprogramming of human CD4+ T cells to enhance effector function

Marco Craveiro et al.

SCIENCE SIGNALING (2017)

Review Oncology

The therapeutic potential of resveratrol: a review of clinical trials

Adi Y. Berman et al.

NPJ PRECISION ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480

Stacey J. Butler et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway

Senthil Selvaraj et al.

MOLECULAR CARCINOGENESIS (2016)

Article Medicine, Research & Experimental

Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers

Christakis Sergides et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)

Review Oncology

Pharmacologic resistance in colorectal cancer: a review

William A. Hammond et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)

Article Integrative & Complementary Medicine

Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis

Lavanya Reddivari et al.

BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)

Article Cardiac & Cardiovascular Systems

Resveratrol promotes differentiation of mouse embryonic stem cells to cardiomyocytes

Hong Ding et al.

CARDIOVASCULAR THERAPEUTICS (2016)

Article Pharmacology & Pharmacy

Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines

Ganesan Muthusamy et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2016)

Article Nanoscience & Nanotechnology

Amphiphilic Copolymeric Micelles for Doxorubicin and. Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer

Li Lv et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)

Review Biochemistry & Molecular Biology

Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

Bowen Du et al.

MOLECULES (2016)

Editorial Material Oncology

Bioactive natural products in cancer prevention and therapy: Progress and promise

Anupam Bishayee et al.

SEMINARS IN CANCER BIOLOGY (2016)

Review Gastroenterology & Hepatology

Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms

Teng-Fei Yin et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

Mechanisms of drug resistance in colon cancer and its therapeutic strategies

Tao Hu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Multidisciplinary Sciences

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

Beth O. van Emburgh et al.

NATURE COMMUNICATIONS (2016)

Article Medicine, Research & Experimental

Resveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells

Miao Feng et al.

MEDICAL SCIENCE MONITOR (2016)

Review Oncology

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

Mary R. Doherty et al.

CANCERS (2016)

Review Cell Biology

Resveratrol supplementation: Where are we now and where should we go?

Marta G. Novelle et al.

AGEING RESEARCH REVIEWS (2015)

Review Oncology

Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp

Khalid O. Alfarouk et al.

CANCER CELL INTERNATIONAL (2015)

Article Medicine, Research & Experimental

The effectiveness of different neuroprotective agents in facial nerve injury: An experimental study

Gokce Tanyeri et al.

LARYNGOSCOPE (2015)

Article Biochemistry & Molecular Biology

Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway

Jing Feng et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)

Article Biochemistry & Molecular Biology

Sirtuin-1 (SIRT1) Is Required for Promoting Chondrogenic Differentiation of Mesenchymal Stem Cells

Constanze Buhrmann et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Cell & Tissue Engineering

The effect of resveratrol on normal and osteoarthritic chondrocyte metabolism

H. J. Kim et al.

BONE & JOINT RESEARCH (2014)

Review Oncology

Dietary Non-nutritive Factors in Targeting of Regulatory Molecules in Colorectal Cancer: An Update

Ashok Kumar Pandurangan et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)

Review Oncology

Improving outcomes in colorectal cancer: Where do we go from here?

Eric Van Cutsem et al.

EUROPEAN JOURNAL OF CANCER (2013)

Review Biochemistry & Molecular Biology

Potential Targets for Colorectal Cancer Prevention

Sally Temraz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Article Biochemistry & Molecular Biology

Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol

Ashley C. Huderson et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)

Article Biochemistry & Molecular Biology

Cancer stem cells

Zuoren Yu et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)

Article Biochemistry & Molecular Biology

Sirt-1 Is Required for the Inhibition of Apoptosis and Inflammatory Responses in Human Tenocytes

Franziska Busch et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Resveratrol Modulates Interleukin-1β-induced Phosphatidylinositol 3-Kinase and Nuclear Factor κB Signaling Pathways in Human Tenocytes

Franziska Busch et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Review Public, Environmental & Occupational Health

Age-associated chronic diseases require age-old medicine: Role of chronic inflammation

Sandeo Prasad et al.

PREVENTIVE MEDICINE (2012)

Article Medicine, Research & Experimental

Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells

Yoo Jin Choi et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)

Article Hematology

Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease

K. Magyar et al.

CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2012)

Article Multidisciplinary Sciences

Bioavailability of resveratrol

Thomas Walle

RESVERATROL AND HEALTH (2011)

Article Cell Biology

Resveratrol Potentiates the Cytotoxic Oxidative Stress Induced by Chemotherapy in Human Colon Cancer Cells

Francisca M. Santandreu et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)

Article Endocrinology & Metabolism

Resveratrol Promotes Osteogenesis of Human Mesenchymal Stem Cells by Upregulating RUNX2 Gene Expression via the SIRT1/FOXO3A Axis

Pei-Chi Tseng et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2011)

Article Food Science & Technology

Enhancing the bioavailability of resveratrol by combining it with piperine

Jeremy J. Johnson et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2011)

Article Oncology

Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis

Xiangli Cui et al.

CANCER PREVENTION RESEARCH (2010)

Article Pharmacology & Pharmacy

Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice

Susana Sanchez-Fidalgo et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2010)

Article Microbiology

Bacterial transformation of dietary lignans in gnotobiotic rats

Anni Woting et al.

FEMS MICROBIOLOGY ECOLOGY (2010)

Review Biochemistry & Molecular Biology

Oxidative stress, inflammation, and cancer How are they linked?

Simone Reuter et al.

FREE RADICAL BIOLOGY AND MEDICINE (2010)

Article Agriculture, Multidisciplinary

trans-Resveratrol Reduces Precancerous Colonic Lesions in Dimethylhydrazine-Treated Rats

Irene Alfaras et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis

M. Sengottuvelan et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2009)

Review Medicine, Research & Experimental

Molecular Targets of Nutraceuticals Derived from Dietary Spices: Potential Role in Suppression of Inflammation and Tumorigenesis

Bharat B. Aggarwal et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2009)

Article Food Science & Technology

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

Luis Almeida et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2009)

Review Food Science & Technology

Resveratrol addiction: To die or not to die

Mehdi Shakibaei et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2009)

Review Medicine, General & Internal

Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.

Sanford D. Markowitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Oncology

Curcumin Synergizes With Resveratrol to Inhibit Colon Cancer

Adhip P. N. Majumdar et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2009)

Article Multidisciplinary Sciences

Phenotypic characterization of human colorectal cancer stem cells

Piero Dalerba et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Pharmacology & Pharmacy

Natural products as a gold mine for arthritis treatment

Dinesh Khanna et al.

CURRENT OPINION IN PHARMACOLOGY (2007)

Review Cell Biology

Complex networks orchestrate epithelial-mesenchymal transitions

JP Thiery et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)

Review Biotechnology & Applied Microbiology

Therapeutic potential of resveratrol: the in vivo evidence

Joseph A. Baur et al.

NATURE REVIEWS DRUG DISCOVERY (2006)

Article Cardiac & Cardiovascular Systems

Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery

O Rakici et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)

Article Multidisciplinary Sciences

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients

TL Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Pharmacology & Pharmacy

High absorption but very low bioavailability of oral resveratrol in humans

T Walle et al.

DRUG METABOLISM AND DISPOSITION (2004)

Article Cell Biology

Snail blocks the cell cycle and confers resistance to cell death

S Vega et al.

GENES & DEVELOPMENT (2004)

Article Biochemistry & Molecular Biology

Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

SS Leonard et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)

Review Oncology

Cancer chemoprevention with dietary phytochemicals

YJ Surh

NATURE REVIEWS CANCER (2003)

Article Pharmacology & Pharmacy

Resveratrol transport and metabolism by human intestinal Caco-2 cells

MI Kaldas et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)

Article Cell Biology

Epithelial-mesenchymal transitions in development and pathologies

JP Thiery

CURRENT OPINION IN CELL BIOLOGY (2003)

Article Agriculture, Multidisciplinary

Plant foods and herbal sources of resveratrol

J Burns et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)